Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Genocea Biosciences

Stocks That Hit 52-Week Lows On Tuesday

On Tuesday, 36 companies achieved new lows for the year.

12 Health Care Stocks Moving In Tuesday's After-Market Session

12 Health Care Stocks Moving In Tuesday's After-Market Session

12 Health Care Stocks Moving In Tuesday's Intraday Session

12 Health Care Stocks Moving In Tuesday's Intraday Session

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Stocks That Hit 52-Week Lows On Tuesday

On Tuesday, 540 companies set new 52-week lows.

Genocea Closes Shop, Delists From NASDAQ

Genocea Biosciences Inc's (NASDAQ:GNCA) board has voted to wind down the company's ongoing operations and terminate the remaining employees except those deemed necessary to complete an orderly wind down. Yesterday, the company delivered formal notice to The Nasdaq Stock Market Inc of its intent to delist voluntarily and its plans to file a…

12 Health Care Stocks Moving In Friday's Intraday Session

Benzinga's Top Ratings Upgrades, Downgrades For April 29, 2022

inkl

Read news from The Economist, FT, and more,
with one subscription

12 Health Care Stocks Moving In Monday's After-Market Session

12 Health Care Stocks Moving In Monday's After-Market Session

12 Health Care Stocks Moving In Tuesday's Intraday Session

12 Health Care Stocks Moving In Tuesday's Intraday Session

12 Health Care Stocks Moving In Friday's Intraday Session

12 Health Care Stocks Moving In Friday's Intraday Session

Recap: Genocea Biosciences Q4 Earnings

Recap: Genocea Biosciences Q4 Earnings

Genocea Biosciences (NASDAQ:GNCA) reported its Q4 earnings results on Thursday, March 10, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Genocea Biosciences Earnings Preview

Genocea Biosciences Earnings Preview

Genocea Biosciences (NASDAQ:GNCA) is set to give its latest quarterly earnings report on Thursday, 2022-03-10. Here's what investors need to know before the announcement. Analysts estimate that Genocea Biosciences will report an earnings per share (EPS) of $-0.20.

Organisations

B of A Securities

Constellation Energy

Lululemon Athletica

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Topics

inkl

Read news from The Economist, FT, and more,
with one subscription

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play